Literature DB >> 26111083

Polymorphisms in adiponectin receptor genes are associated with lipodystrophy-related phenotypes in HIV-infected patients receiving antiretroviral therapy.

J K Castilhos1, E Sprinz2, R K Lazzaretti2, R Kuhmmer2, V S Mattevi1.   

Abstract

OBJECTIVES: Adiponectin is a circulating peptide secreted by mature adipocytes that may act as a regulator of glucose and lipid metabolism. This study aimed to investigate the association between genetic variability in the adiponectin receptor genes ADIPOR1 (adiponectin receptor 1) and ADIPOR2 and lipodystrophy and its related anthropometric and metabolic phenotypes in HIV-infected patients on highly active antiretroviral therapy (HAART).
METHODS: We studied six single nucleotide polymorphisms (SNPs) in the adiponectin receptor genes ADIPOR1 (rs1342387 and rs10920533) and ADIPOR2 (rs11061925, rs10773983, rs929434 and rs767870) and their association with adiponectin plasma levels, lipodystrophy subtypes and other parameters linked to glucose and lipid metabolism involved in the lipodystrophic syndrome. The genotypes of 407 HIV-infected patients receiving HAART were investigated using real-time polymerase chain reaction. Mean biochemical and anthropometrical parameters were compared between the different genotypes using analysis of variance.
RESULTS: Two ADIPOR2 SNPs (rs11061925 and rs929434) were associated with fasting plasma triglyceride concentrations in the entire sample. Stronger significant associations were found between these SNPs and biochemical parameters (levels of triglycerides, total cholesterol, adiponectin and glucose) in men. We did not find any significant associations with ADIPOR1 gene variants.
CONCLUSIONS: SNPs in the ADIPOR2 gene appear to be involved in the metabolic alterations in HIV-infected men receiving HAART.
© 2015 British HIV Association.

Entities:  

Keywords:  HIV; adiponectin receptors; dyslipidaemia; highly active antiretroviral therapy; lipodystrophy

Mesh:

Substances:

Year:  2015        PMID: 26111083     DOI: 10.1111/hiv.12250

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  5 in total

1.  Deciphering the molecular mechanisms involved in HIV-associated lipoatrophy by transcriptomics: a pilot study.

Authors:  Patricia Pérez-Matute; María Iñiguez; Emma Recio-Fernández; José-Antonio Oteo
Journal:  J Physiol Biochem       Date:  2017-01-10       Impact factor: 4.158

2.  Variations in ADIPOR1 But Not ADIPOR2 are Associated With Hypertriglyceridemia and Diabetes in an Admixed Latin American Population.

Authors:  Gustavo Mora-García; María S Ruiz-Díaz; Fabian Espitia-Almeida; Doris Gómez-Camargo
Journal:  Rev Diabet Stud       Date:  2017-10-10

Review 3.  Severe insulin resistance syndromes.

Authors:  Angeliki M Angelidi; Andreas Filippaios; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

4.  miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis.

Authors:  Elena Bresciani; Nicola Squillace; Valentina Orsini; Roberta Piolini; Laura Rizzi; Laura Molteni; Ramona Meanti; Alessandro Soria; Giuseppe Lapadula; Alessandra Bandera; Andrea Gori; Paolo Bonfanti; Robert John Omeljaniuk; Vittorio Locatelli; Antonio Torsello
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

5.  Pharmacogenetics of HIV therapy: State of the art in Latin American countries.

Authors:  Camila de Almeida Velozo; Flávia Rachel Moreira Lamarão; Lucia Elena Alvarado-Arnez; Cynthia Chester Cardoso
Journal:  Genet Mol Biol       Date:  2022-09-30       Impact factor: 2.087

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.